Economic and care considerations of Marfan syndrome

References

• Judge DP, Dietz HC. Marfan’s syndrome. The Lancet. 2005;366(9501):1965–1976.
   PubMed Web of Science ®Google Scholar
• Dean JCS. Marfan syndrome: clinical diagnosis and management. Eur J Hum Genet. 2007;15(7):724–733.
   PubMed Web of Science ®Google Scholar
• Gray JR, Bridges AB, Faed MJ, et al. Ascertainment and severity of Marfan syndrome in a Scottish population. J Med Genet. 1994;31(1):51–54.
   PubMed Web of Science ®Google Scholar
• von Kodolitsch Y, De Backer J, Schüler H, et al. Perspectives on the revised Ghent criteria for the diagnosis of Marfan syndrome. Appl Clin Genet. 2015;8(June 2015):137—155.
   PubMedGoogle Scholar
• Pyeritz RE. Marfan syndrome: 30 years of research equals 30 years of additional life expectancy. Heart. 2009;95(3):173–175.
   PubMed Web of Science ®Google Scholar
• Kainulainen K, Pulkkinen L, Savolainen A, et al. Location on chromosome 15 of the gene defect causing Marfan syndrome. New England J Med. 1990;323(14):935–939.
   PubMed Web of Science ®Google Scholar
• Dietz H, Pyeritz R. Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders. Hum Mol Genet. 1995;4(suppl 1):1799–1809.
   PubMed Web of Science ®Google Scholar
• Pereiralrz L., Andrikopoulos K, Tian J, et al. Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome. Nat Genet. 1997;17(2):218–222.
   Web of Science ®Google Scholar
• Sakai LY, Keene DR, Engvall E. Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils. J Cell Biol. 1986;103(6):2499–2509.
   PubMed Web of Science ®Google Scholar
• Singh KK, Rommel K, Mishra A, et al. TGFBR1 and TGFBR2 mutations in patients with features of Marfan syndrome and Loeys-Dietz syndrome. Hum Mutat. 2006;27(8):770–777.
   PubMed Web of Science ®Google Scholar
• Loeys BL, Chen J, Neptune ER, et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet. 2005;37(3):275–281.
   PubMed Web of Science ®Google Scholar
• Faivre L, Collod-Beroud G, Callewaert B, et al. Pathogenic FBN1 mutations in 146 adults not meeting clinical diagnostic criteria for Marfan syndrome: further delineation of type 1 fibrillinopathies and focus on patients with an isolated major criterion. Am J Med Genet. 2009;149A(5):854–860.
   PubMed Web of Science ®Google Scholar
• Rippe M, De Backer J, Kutsche K, et al. Mitral valve prolapse syndrome and MASS phenotype: Stability of aortic dilatation but progression of mitral valve prolapse. IJC Heart & Vasculature. 2016;10:39–46.
   PubMed Web of Science ®Google Scholar
• Tsipouras P, Del Mastro R, Sarfarazi M, et al. Genetic linkage of the Marfan syndrome, ectopia lentis, and congenital contractural arachnodactyly to the fibrillin genes on chromosomes 15 and 5. N Engl J Med. 1992;326(14):905–909.
   PubMed Web of Science ®Google Scholar
• Robinson PN, Booms P, Katzke S, et al. Mutations of FBN1 and genotype–phenotype correlations in Marfan syndrome and related fibrillinopathies. Hum Mutat. 2002;20(3):153–161.
   PubMed Web of Science ®Google Scholar
• Loeys B, Nuytinck L, Delvaux I, et al. GEnotype and phenotype analysis of 171 patients referred for molecular study of the fibrillin-1 gene fbn1 because of suspected marfan syndrome. Arch Intern Med. 2001;161(20):2447–2454.
   PubMedGoogle Scholar
• Sheikhzadeh S, Kade C, Keyser B, et al. Analysis of phenotype and genotype information for the diagnosis of Marfan syndrome. Clin Genet. 2012;82(3):240–247.
   PubMed Web of Science ®Google Scholar
• De Paepe A, Devereux RB, Dietz HC, et al. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet. 1996;62(4):417–426.
   PubMed Web of Science ®Google Scholar
• Yetman AT, McCrindle BW. The prevalence and clinical impact of obesity in adults with Marfan syndrome. Can J Cardiol. 2010;26(4):e137–e139.
   PubMedGoogle Scholar
• Robins P, Moe J, Winter R. Scoliosis in Marfan’s syndrome. Its characteristics and results of treatment in thirty-five patients. J Bone Jt Surg. 1975;57(3):358–368.
   PubMed Web of Science ®Google Scholar
• Carter N, Duncan E, Wordsworth P. Bone mineral density in adults with Marfan syndrome. Rheumatology. 2000;39(3):307–309.
   PubMed Web of Science ®Google Scholar
• Le Parc MJ, Plantin P, Jondeau G, et al. Bone Mineral Density in Sixty Adult Patients with Marfan Syndrome. Osteoporos Int. 1999;10(6):475–479.
   PubMed Web of Science ®Google Scholar
• Sheikhzadeh S, Kusch ML, Rybczynski M, et al. A simple clinical model to estimate the probability of Marfan syndrome. QJM. 2012;105(6):527–535.
   PubMed Web of Science ®Google Scholar
• Lundby R, Rand-Hendriksen S, Hald JK, et al. Dural Ectasia in Marfan syndrome: A case control study. Am J Neuroradiology. 2009;30(8):1534–1540.
   PubMed Web of Science ®Google Scholar
• Pyeritz R., Fishman EK, Bernhardt BA, et al. Dural ectasia is a common feature of the Marfan syndrome. Am J Hum Genet. 1988;43(5):726.
   PubMed Web of Science ®Google Scholar
• Stern WE. Dural ectasia and the Marfan syndrome. J Neurosurg. 1988;69(2):221–227.
   PubMed Web of Science ®Google Scholar
• Sheikhzadeh S, Sondermann C, Rybczynski M, et al. Comprehensive analysis of dural ectasia in 150 patients with a causative FBN1 mutation. Clin Genet. 2014;86(3):238–245.
   PubMed Web of Science ®Google Scholar
• Maumenee IH. The eye in the Marfan syndrome. Trans Am Ophthalmol Soc. 1981;79:684–733.
   PubMedGoogle Scholar
• Lally DR, Monsonego J. Ectopia Lentis in Marfan’s syndrome. N Engl J Med. 2014;371(19):e28.
   PubMed Web of Science ®Google Scholar
• Nemet AY, Assia EI, Apple DJ, et al. Current concepts of ocular manifestations in Marfan syndrome. Surv Ophthalmol. 2006;51(6):561–575.
   PubMed Web of Science ®Google Scholar
• Pyeritz RE, McKusick VA. The Marfan syndrome: diagnosis and management. New England J Med. 1979;300(14):772–777.
   PubMed Web of Science ®Google Scholar
• Aydin A, Adsay BA, Sheikhzadeh S, et al. Observational cohort study of ventricular arrhythmia in adults with Marfan syndrome caused by FBN1 mutations. PLoS One. 2013;8(12):e81281.
   PubMed Web of Science ®Google Scholar
• Aburawi EH, O’Sullivan J. Relation of aortic root dilatation and age in Marfan’s syndrome. Eur Heart J. 2007;28(3):376–379.
   PubMed Web of Science ®Google Scholar
• Brown OR, DeMots H, Kloster FE, et al. Aortic root dilatation and mitral valve prolapse in Marfan’s syndrome: an ECHOCARDIOgraphic study. Circulation. 1975;52(4):651–657.
   PubMed Web of Science ®Google Scholar
• Kiotsekoglou A., Sutherland G R,Moggridge J.,et al. Impaired right ventricular systolic function demonstrated by reduced atrioventricular plane displacement in adults with Marfan syndrome. Eur Heart J Cardiovasc Imaging. 2009;10(2):295–302.
   Web of Science ®Google Scholar
• Rybczynski M, Bernhardt AMJ, Rehder U, et al. The spectrum of syndromes and manifestations in individuals screened for suspected Marfan syndrome. Am J Med Genet. 2008;146A(24):3157–3166.
   PubMed Web of Science ®Google Scholar
• Bernhardt A.M., Treede H, Detter C, et al. Results of modern mitral valve repair in patients with Marfan syndrome. Thorac Cardiovasc Surg. 2014;62(1):35–41.
   PubMed Web of Science ®Google Scholar
• Rybczynski M, Treede H, Sheikhzadeh S, et al. Predictors of outcome of mitral valve prolapse in patients with the marfan syndrome. Am J Cardiol. 2011;107(2):268–274.
   PubMed Web of Science ®Google Scholar
• Kuhne, K., Keyser B, Groene EF, et al. FBN1 gene mutation characteristics and clinical features for the prediction of mitral valve disease progression. Int J Cardiol. 2012;168:953–959.
   PubMed Web of Science ®Google Scholar
• Rybczynski M, Mir TS, Sheikhzadeh S, et al. Frequency and age-related course of mitral valve dysfunction in the Marfan syndrome. Am J Cardiol. 2010;106(7):1048–1053.
   PubMed Web of Science ®Google Scholar
• Faivre L, Collod-Beroud G, Loeys BL, et al. Effect of mutation type and location on clinical outcome in 1,013 Probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. Am J Hum Genet. 2007;81(3):454–466.
   PubMed Web of Science ®Google Scholar
• Rand-Hendriksen S, Johansen H, Semb SO, et al. Health-related quality of life in Marfan syndrome: a cross-sectional study of short form 36 in 84 adults with a verified diagnosis. Genet Med. 2010;12(8):517–524.
   PubMed Web of Science ®Google Scholar
• von Kodolitsch Y, Blankart CR, Vogler M, et al. Genetics and prevention of genetic aortic syndromes (GAS) and of the Marfan syndrome. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 2014;58(2):146–153.
   Web of Science ®Google Scholar
• De Backer J, Renard M, Campens L, et al. Marfan syndrome and related heritable thoracic aortic Aneurysms and Dissections. Curr Pharm Des. 2015;21(28):4061–4075.
   PubMed Web of Science ®Google Scholar
• Habashi JP, Judge DP, Holm TM, et al. Losartan, an AT1 Antagonist, prevents aortic Aneurysm in a mouse model of Marfan syndrome. Science. 2006;312(5770):117–121.
   PubMed Web of Science ®Google Scholar
• Travis J. Old drug, new hope for Marfan syndrome. Science. 2006;312(5770):36–37.
   PubMed Web of Science ®Google Scholar
• Lacro RV, Dietz HC, Sleeper LA, et al. Atenolol versus losartan in children and young adults with Marfan’s syndrome. N Engl J Med. 2014;371(22):2061–2071.
   PubMed Web of Science ®Google Scholar
• Braverman AC, Harris KM, Kovacs RJ, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 7: aortic diseases, including marfan syndrome: a scientific statement from the American heart association and American college of cardiology. J Am Coll Cardiol. 2015;66(21):2398–2405.
   PubMed Web of Science ®Google Scholar
• Erbel, R., Aboyans V, Boileau C, et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adultThe task force for the diagnosis and treatment of aortic diseases of the European Society of Cardiology (ESC). Eur Heart J. 2014;35(41):2873–2926.
   Google Scholar
• von Kodolitsch Y, Robinson P, Berger J, et al. When should surgery be performed in marfan syndrome and other connective tissue disorders to protect against type a dissection? In: Bonser RS, Editors. Controversies in Aortic dissection and Aneurysmal disease. London: Springer; 2014. p. 17–47.
   Google Scholar
• Zanotti G, Vricella L, Cameron D. Thoracic aortic aneurysm syndrome in children. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2008;11:11–21.
   Google Scholar
• David TE, Feindel CM. An aortic valve-sparing operation for patients with aortic incompetence and aneurysm of the ascending aorta. J Thorac Cardiovasc Surg. 1992;103(4): 617–621; discussion 622.
   Web of Science ®Google Scholar
• Settepani F, Ornaghi D, Barbone A, et al. Aortic valve-sparing operations in patients with aneurysms of the aortic root or ascending aorta: preliminary results. Interact Cardiovasc Thorac Surg. 2005;4(2):137–139.
   PubMedGoogle Scholar
• Schäfers H-J, Aicher D, Langer F. Correction of leaflet prolapse in valve-preserving aortic replacement: pushing the limits? Ann Thorac Surg. 2002;74(5):S1762–S1764.
   PubMed Web of Science ®Google Scholar
• Graeter TP, Aicher D, Langer F, et al. Mid-term results of aortic valve preservation: remodelling vs. reimplantation. Thorac Cardiovasc Surg. 2002;50(1):21–24.
   PubMed Web of Science ®Google Scholar
• Horstkotte D, Schulte H, Bircks W, et al. Unexpected findings concerning thromboembolic complications and anticoagulation after complete 10 year follow-up of patients with St. Jude medical prostheses. J Heart Valve Dis. 1993;2:291–301.
   PubMedGoogle Scholar
• Bernhardt AM, Treede H, Rybczynski M, et al. Comparison of aortic root replacement in patients with Marfan syndrome. Eur J Cardiothorac Surg. 2011;40(5):1052–1057.
   PubMed Web of Science ®Google Scholar
• Yacoub M., Fagan A, Stassano P, et al. Results of valve conserving operations for aortic regurgitation. Circulation. 1983;1983(68):III-321 (abstract).
   Google Scholar
• Tian D, Rahnavardi M, Yan TD. Aortic valve sparing operations in aortic root aneurysms: remodeling or reimplantation? Ann Cardiothorac Surg. 2013;2(1):44–52.
   PubMedGoogle Scholar
• Benedetto U, Melina G, Takkenberg JJM, et al. Surgical management of aortic root disease in Marfan syndrome: a systematic review and meta-analysis. Heart (British Cardiac Society). 2011;97(12):955–958.
   PubMed Web of Science ®Google Scholar
• Gott VL, Greene PS, Alejo DE, et al. Replacement of the aortic root in patients with Marfan’s syndrome. N Engl J Med. 1999;340(17):1307–1313.
   PubMed Web of Science ®Google Scholar
• Gott VL, Cameron DE, Alejo DE, et al. Aortic root replacement in 271 Marfan patients: A 24-year experience. Ann Thorac Surg. 2002;73(2):438–443.
   PubMed Web of Science ®Google Scholar
• Groenink M, Lohuis TA, Tijssen JG, et al. Survival and complication free survival in Marfan’s syndrome: implications of current guidelines. Heart. 1999;82(4):499–504.
   PubMed Web of Science ®Google Scholar
• Ryosaka M, Omoto K, Nozaki T, et al. Successful kidney transplantation for end-stage renal disease in Marfan’s syndrome. Case Rep Transplant. 2013;2013:4.
   Google Scholar
• Lipton GE, Guille JT, Kumar SJ. Surgical treatment of scoliosis in Marfan syndrome: guidelines for a successful outcome. J Pediatr Orthopaedics. 2002;22(3):302–307.
   PubMed Web of Science ®Google Scholar
• Knosalla C, Weng Y-G, Hammerschmidt R, et al. Orthotopic heart transplantation in patients with Marfan syndrome. Ann Thorac Surg. 2007;83(5):1691–1695.
   PubMed Web of Science ®Google Scholar
• Groth KA, Hove H, Kyhl K, et al. Prevalence, incidence, and age at diagnosis in Marfan syndrome. Orphanet J Rare Dis. 2015;10:153.
   PubMed Web of Science ®Google Scholar
• von Kodolitsch Y, Bernhardt AM, Kölbel T, et al. Maximizing therapeutic success: The key concepts of individualized medical strategy (IMS). Cogent Med. 2015;2(1):1109742.
   Google Scholar
• Manow M-L, Paulsen N, Rybczynski M, et al. Analysis of costs and profits of ambulatory care of Marfan patients after initiation of a novel German legal directive (§ 116 b SGB V). Med Klin. 2010;105(8):529–537.
   Google Scholar
• Achelrod, D., Blankart CR, Linder R, et al. The economic impact of Marfan syndrome: a non-experimental, retrospective, population-based matched cohort study. Orphanet J Rare Dis. 2014;9(1):1–12.
   PubMed Web of Science ®Google Scholar
• Loeys BL, Dietz HC, Braverman AC, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010;47(7):476–485.
   PubMed Web of Science ®Google Scholar
• von Kodolitsch Y, Rybczynski M, Vogler M. The role of the multidisciplinary healthcare team in the management of patients with Marfan syndrome. J Multidiscip Healthc. 2016. Forthcoming
   Web of Science ®Google Scholar
• Halliday DJ, Hutchinson S, Lonie L, et al. Twelve novel FBN1 mutations in Marfan syndrome and Marfan related phenotypes test the feasibility of FBN1 mutation testing in clinical practice. J Med Genet. 2002;39(8):589–593.
   PubMed Web of Science ®Google Scholar
• von Kodolitsch Y, Kutsche K. Interpretation of sequence variants of the FBN1 gene: analog or digital? A commentary on decreased frequency of FBN1 missense variants in Ghent criteria-positive Marfan syndrome and characterization of novel FBN1 variants. J Hum Genet. 2015;60:465–466.
   PubMed Web of Science ®Google Scholar
• Roll K. The influence of regional health care structures on delay in diagnosis of rare diseases: the case of Marfan syndrome. Health Policy. 2012;105(2–3):119–127.
   PubMed Web of Science ®Google Scholar
• Jondeau G, Detaint D, Tubach F, et al. Aortic event rate in the Marfan population: a cohort study. Circulation. 2012;125(2):226–232.
   PubMed Web of Science ®Google Scholar